Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mirjana S. Rajkovic"'
Autor:
A. Rechner, Anna L. Kobsar, Andreas Schäfer, Juergen Koessler, Ulrike Flierl, Stephanie Pfoertsch, Udo Steigerwald, Mirjana S. Rajkovic, Ulrich Walter, Johann Bauersachs
Publikováno v:
Platelets. 22:19-25
Insufficient response on antiplatelet medication has become an intensively discussed issue because of the risk factor of recurrent adverse cardiovascular events. However, the monitoring of antiplatelet therapy requires appropriate, robust and reliabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b23062fccdcbddbe1b3db870cb0c5856
https://doi.org/10.3109/09537104.2010.514967
https://doi.org/10.3109/09537104.2010.514967
Autor:
Juergen, Koessler, Anna L, Kobsar, Mirjana S, Rajkovic, Andreas, Schafer, Ulrike, Flierl, Stephanie, Pfoertsch, Johann, Bauersachs, Udo, Steigerwald, Andreas R, Rechner, Ulrich, Walter
Publikováno v:
Platelets. 22(1)
Insufficient response on antiplatelet medication has become an intensively discussed issue because of the risk factor of recurrent adverse cardiovascular events. However, the monitoring of antiplatelet therapy requires appropriate, robust and reliabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3dc109435dac2c1b9cc5a0ab8bbc237e
https://pubmed.ncbi.nlm.nih.gov/20873965
https://pubmed.ncbi.nlm.nih.gov/20873965
Autor:
Anna Kobsar, Ulrich Walter, Mirjana S. Rajkovic, Kirsten Brunner, Udo Steigerwald, Juergen Koessler
Publikováno v:
Platelets. 21(2)
The rationale for monitoring platelet inhibition by thienopyridines for the identification of patients at risk for future recurrent arterial thrombosis or ischemic events is intensively discussed, as well as which monitoring systems are appropriate,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ebbc3146fdec1e561c692ffe171f0ab
https://pubmed.ncbi.nlm.nih.gov/20085435
https://pubmed.ncbi.nlm.nih.gov/20085435